Read full report (PDF) Identifying timely topics and trends in the sub-$200 million market. Research Type: Emerging | Timeliness: Current | Date: March 05, 2024MedX Health Corp. TSXV: MDX | …
Health Partners, the UK’s largest non-hospital private healthcare services provider, with over two million patients across 550+ corporate, insurance and government clients, announced its intention to partner with MedX after …
MISSISSAUGA, ON — January 25, 2024 – MedX Health Corp. (“MedX” or the “Company”) (TSX VENTURE: MDX) is pleased to announce that it has appointed Dr. Paul Cohen, a board-certified dermatologist and Fellow of the Royal College of Physicians and Surgeons of Canada, as Medical Spokesperson. Dr. Cohen is also a diplomat of the American Board of Dermatology and is a member of numerous associations, including the Canadian Dermatological Association and the Toronto Dermatological Society.
Mississauga, ON, November 14, 2023. MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced today that, it has submitted for Final Acceptance from the TSXV and has closed the non-brokered Private Placement which was previously announced on August 30, 2023. The placement, to accredited investors, raised $1,020,000 by issuance of 14,571,428 units at $0.07per unit (“Unit”)
Raporun tamamını okuyun (PDF) 200 milyon doların altındaki pazardaki güncel konuların ve trendlerin belirlenmesi. Araştırma Türü: Ortaya Çıkan Zamanlılık: Güncel Tarih: 28 Temmuz 2023 MedX Health Corp. MDX 0,065$TSXV Değişimi | OTC:MDXHF…
MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce that Stephen Lockyer has been appointed as Chief Executive Officer, effective immediately, in place of Naman Damaghlatrous, who has resigned both as an officer and director of the Company.
PharmaChoice Canada, one of Canada’s fastest‐growing pharmacy groups, with more than 1000
independent pharmacy owners and operators, announces its partnership with MedX Health to launch a
pilot program of MedX’s DermSecure® Screening Platform
Türkçe 
English (Canada) 
Français